Search

everythinglearnresearchcommunity

for

Search:↓

The guidelines help doctors diagnose and treat hormone-related disorders in women.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Hormones and genetics affect hair growth and patterns, with some changes reversible and others not.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Hirsutism, excessive hair growth in women, is often caused by PCOS and can be managed with medication and personalized treatment plans.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Blocking BACE1 and BACE2 enzymes causes hair color loss in mice.

Some drugs may reduce prostatitis symptoms short-term with few side effects.

The document concludes that treating PCOS requires a combination of drugs to manage reproductive and metabolic symptoms, with more research needed on combination therapies.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Hair growth and health are influenced by stress and hormones.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Stress may affect hair growth by influencing hair follicle development and could contribute to hair loss.

Myo-inositol and D-chiro-inositol improve hormonal and physical symptoms in teenage girls with PCOS.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

Minoxidil and finasteride are effective for treating hair loss, with dutasteride showing potential but with side effects.

Endocrine therapy helps with reproductive and metabolic issues in women with PCOS.

The skin acts like an endocrine organ, producing hormones that affect various body functions and skin health, and understanding this can lead to new treatments.